![](/img/cover-not-exists.png)
Pazopanib as Second-line Antiangiogenic Treatment in Metastatic Renal Cell Carcinoma After Tyrosine Kinase Inhibitor (TKI) Failure: A Phase 2 Trial Exploring Immune-related Biomarkers for Testing in the Post-immunotherapy/TKI Era
Bellmunt, Joaquim, Esteban, Emilio, Muro, Xavier García del, Sepúlveda, Juan Manuel, Maroto, Pablo, Gallardo, Enrique, Alba, Aranzazu González del, Etxaniz, Olatz, Guix, Marta, Larriba, Jose Luis GonzLanguage:
english
Journal:
European Urology Oncology
DOI:
10.1016/j.euo.2019.07.014
Date:
August, 2019
File:
PDF, 379 KB
english, 2019